Medtronic plc

NYSE:MDT

Medical - Devices

Healthcare
$100.72 +0.96%

+$0.75 today

Market cap
$128.84B
Beta
0.60
P/E (TTM)
21.1
EPS (TTM)
$3.74
Dividend yield
3.60%
52W Low $73.31High $106.33

Volume 6.47M

Average 11.36M

MDT Total Equity

Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.

Medtronic plcNYSE: MDT

Total Equity · Q1 FY2027 · quarter ended Jul 2026

Total equity rises 5.6% from a year ago

Total equity stood at $50.85B at the end of Q1 FY2027, up 5.6% from a year earlier and up 1.6% from the prior quarter. Over 3 fiscal years it compounded at -1.0% a year.

Context

  • Total equity amounted to 54.5% of total assets at the end of Q1 FY2027, up 1.6 pp from a year earlier.
  • Total equity increased in 1 of the last 3 fiscal years.

What to watch

Whether total equity keeps rising in the next quarterly balance sheet after a +5.6% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJul 2026
$50.85B+1.6% QoQ
Last fiscal yearApr 2026
$50.07B+3.8% YoY
Year agoJul 2025
$48.13B+5.6% since
Total Equity past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+5.6%——
1 year+3.8%——
3-year CAGR-1.0%——
5-year CAGR——
10-year CAGR——

Total Equity history

USD · from the balance sheet

Latest · FY2026
50.07B USD
Year-over-year change
+3.8%
4-year CAGR
-1.3%

Total Equity vs competitors

How MDT compares with its peers on the latest reported figures

  • Peers report in different currencies, so total equity is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +5.6% is the 7th highest of 9, against a peer median of +12.2%.
  • Total equity amounts to 54.5% of total assets for MDT, versus a peer median of 55.5%.
MDT Competitors
Total Equity for MDT and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
MDTMedtronic plcJul 2026$50.85B USD+5.6%-1.0%54.5%
BSXBoston Scientific CorporationJun 2026$25.17B USD+11.1%+11.7%55.7%
SYKStryker CorporationJun 2026$23.99B USD+13.2%+10.5%50.0%
ZBHZimmer Biomet Holdings, Inc.Jun 2026$12.63B USD+0.8%+1.8%55.4%
PHGKoninklijke Philips N.V.Jun 2026€11.48B EUR+10.3%-6.1%43.0%
EWEdwards Lifesciences CorporationJun 2026$10.72B USD+1.1%+21.2%77.3%
PENPenumbra, Inc.Jun 2026$1.53B USD+18.3%+12.6%77.5%
LIVNLivaNova PLCSep 2026$1.37B USD+18.6%-0.2%50.6%
AVRAnteris Technologies Global Corp.Mar 2026$278.41M USD+545.8%—94.5%
Peer median (excluding MDT) —+12.2%+10.5%55.5%

Competitors are the stored peer set for MDT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2022
Apr 2022
FY2023
Apr 2023
FY2024
Apr 2024
FY2025
Apr 2025
FY2026
Apr 2026
Cash & Equivalents3.71B1.54B1.28B2.22B1.95B
Short-term Investments6.86B6.42B6.72B6.75B7.27B
Net Receivables5.55B6B6.13B6.52B6.64B
Inventory4.62B5.29B5.22B5.48B5.95B
Other Current Assets2.32B2.43B2.59B2.86B2.97B
Total Current Assets23.06B21.68B21.94B23.81B24.79B
Property, Plant & Equipment (Net)5.41B5.57B6.13B6.84B7.42B
Goodwill40.5B41.43B40.99B41.74B42.59B
Intangible Assets15.59B14.84B13.23B11.67B10.15B
Long-term Investments00000
Tax Assets00000
Other Non-current Assets6.41B7.44B7.7B7.62B8.09B
Total Non-current Assets67.92B69.27B68.05B67.87B68.24B
Total Assets90.98B90.95B89.98B91.68B93.03B
Account Payables2.28B2.66B2.41B2.45B2.64B
Short-term Debt3.74B13M1.09B2.87B1.78B
Tax Payables704M840M1.33B0914M
Deferred Revenue00000
Other Current Liabilities2.12B1.95B2.38B2.52B2.68B
Total Current Liabilities12.39B9.05B10.79B12.88B11.66B
Long-term Debt20.32B24.29B23.88B25.59B26.12B
Deferred Tax Liabilities884M708M515M403M362M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities4.61B5.18B4.33B4.5B4.76B
Total Non-current Liabilities25.87B30.23B28.77B30.55B31.3B
Total Liabilities38.26B39.28B39.56B43.42B42.96B
Common Stock00000
Retained Earnings30.25B30.39B30.4B31.48B32.64B
Accumulated OCI(2.27B)(3.5B)(3.32B)(4.28B)(4.1B)
Other Stockholders Equity000(1M)0
Minority Interest171M182M206M232M609M
Total Equity52.72B51.67B50.42B48.26B50.07B
Total Debt24.11B24.36B25.02B28.52B27.96B
Net Debt20.4B22.82B23.74B26.3B26.01B

Medtronic plc

NYSE:MDT

Intrinsic Alpha fair value

Locked

Current Price

$100.72

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.